IFM Investors Pty Ltd increased its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 40.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 25,035 shares of the medical instruments supplier’s stock after buying an additional 7,158 shares during the quarter. IFM Investors Pty Ltd’s holdings in DENTSPLY SIRONA were worth $1,335,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in DENTSPLY SIRONA by 7.0% during the second quarter. Vanguard Group Inc. now owns 25,969,056 shares of the medical instruments supplier’s stock worth $1,515,556,000 after buying an additional 1,688,546 shares in the last quarter. BlackRock Inc. raised its position in DENTSPLY SIRONA by 3.2% in the second quarter. BlackRock Inc. now owns 14,735,875 shares of the medical instruments supplier’s stock valued at $859,985,000 after purchasing an additional 458,934 shares during the period. Price T Rowe Associates Inc. MD raised its position in DENTSPLY SIRONA by 1.6% in the second quarter. Price T Rowe Associates Inc. MD now owns 5,471,623 shares of the medical instruments supplier’s stock valued at $319,324,000 after purchasing an additional 87,294 shares during the period. Atlanta Capital Management Co. L L C raised its position in DENTSPLY SIRONA by 0.8% in the second quarter. Atlanta Capital Management Co. L L C now owns 4,673,039 shares of the medical instruments supplier’s stock valued at $272,719,000 after purchasing an additional 39,156 shares during the period. Finally, Northern Trust Corp raised its position in DENTSPLY SIRONA by 12.2% in the second quarter. Northern Trust Corp now owns 2,919,933 shares of the medical instruments supplier’s stock valued at $170,407,000 after purchasing an additional 317,282 shares during the period. Hedge funds and other institutional investors own 93.46% of the company’s stock.
Shares of NASDAQ XRAY traded up $0.34 during trading on Friday, reaching $57.42. The stock had a trading volume of 2,699,300 shares, compared to its average volume of 1,735,074. The business’s 50-day moving average price is $53.88 and its 200-day moving average price is $54.19. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. The company has a market cap of $12.31 billion, a P/E ratio of 28.57, a PEG ratio of 1.97 and a beta of 0.96. DENTSPLY SIRONA Inc has a fifty-two week low of $34.93 and a fifty-two week high of $60.15.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.57 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.07. The firm had revenue of $962.10 million during the quarter, compared to the consensus estimate of $940.38 million. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The firm’s revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.38 EPS. Analysts forecast that DENTSPLY SIRONA Inc will post 2.39 EPS for the current fiscal year.
A number of research firms have commented on XRAY. ValuEngine downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Barclays lifted their target price on DENTSPLY SIRONA from $55.00 to $58.00 and gave the company an “equal weight” rating in a research report on Friday. Barrington Research reaffirmed a “buy” rating and issued a $63.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. Stifel Nicolaus lifted their price objective on DENTSPLY SIRONA from $61.00 to $63.00 and gave the company a “buy” rating in a research note on Friday. Finally, Evercore ISI started coverage on DENTSPLY SIRONA in a research note on Friday, July 26th. They issued an “in-line” rating for the company. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $57.37.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
See Also: What Are Cryptocurrencies?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.